Biologics are transforming the healthcare landscape, broadening treatment options, and improving patient outcomes. The growing number of approved biologics reflects ongoing innovation, promising further advancements in medicine. Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development to set yourself up for future success.

Simplify Your Move from a Vial to a Prefilled Syringe: Lifecycle Planning for Containment and Delivery of Biologics Drug Products

In this whitepaper, we will discuss how:

Read time :  clock 15 minutes

Prefilled SyringeThe selection of container closure materials can reduce time in your packaging development work

Particle AnalysisSelecting container components with the same material composition can support your drug launch in a vial and simplify your futuretransition to a prefilled syringe

CollaborationCollaborating with your packaging supplier early in your drug development can help you navigate increasingly complex regulatory requirements

 Lifecycle Planning for Containment and Delivery of Biologics Drug Products

Captcha

Simplify Your Move from a Vial to a Prefilled Syringe